LoadingLoadingCookies show us what works. Privacy
Cookies show us what works. Privacy
LoadingCookies show us what works. Privacy
29 funds hold it · Insiders net selling
Net selling: insiders sold $99.9M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Nov 12, 2026
Period ending
Sep 30, 2026
Earnings per share
-$0.20 expected
Revenue
Yahoo Finance
Estimates as of Nov 13, 2026
EPS expected
-$0.31 to -$0.04
Revenue expected
8 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Sep 30, 2026Reported Nov 12, 2026 | -$0.32est. -$0.20 | -56.95%miss | $126.6MYahoo Finance | +27.9%from $99.0M |
| Jun 30, 2026Reported Aug 3, 2026 | -$0.56est. -$0.28 | -98.46%miss | $118.4MSEC filing | +23.2%from $96.1M |
| Mar 31, 2026Reported May 4, 2026 | -$0.60est. -$0.53 | -12.58%miss | $110.7MSEC filing | +19.3%from $92.8M |
| Dec 31, 2025Reported Feb 2, 2026 | -$0.50est. -$0.52 | +3.85%beat | $103.7MSEC filing | +16.9%from $88.7M |
| Sep 30, 2025Reported Nov 14, 2025 | -$0.45est. -$0.50 | +10.00%beat | $99.0MAlpha Vantage | +16.9%from $84.7M |
| Jun 30, 2025Reported Aug 4, 2025 | -$0.47est. -$0.57 | +17.54%beat | $96.1MSEC filing | +17.9%from $81.5M |
| Mar 31, 2025Reported May 5, 2025 | -$0.66est. -$0.56 | -17.86%miss | $92.8MSEC filing | +23.2%from $75.3M |
| Dec 31, 2024Reported Feb 3, 2025 | -$0.53est. -$0.63 | +15.87%beat | $88.7MSEC filing | +24.1%from $71.5M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $99.0M | $103.7M | $110.7M | $118.4M |
| Cost of what it sold | $48.2M | $49.7M | $53.6M | $55.9M |
| Gross profit | $50.8M | $54.0M | $57.1M | $62.5M |
| What it spent | ||||
| Research and development | $17.0M | $17.1M | $19.7M | $18.0M |
| Sales and admin | $56.8M | $69.9M | $76.1M | $80.7M |
| Other operating costs | $7.0M | — | — | — |
| Total operating expenses | $80.8M | $86.9M | $95.8M | $98.7M |
| What was left | ||||
| Operating profit | -$29.9M | -$32.9M | -$38.7M | -$36.3M |
| Profit before tax | -$26.9M | -$30.3M | -$44.0M | -$34.7M |
| Tax | $256.0K | $253.0K | $43.0K | -$311.0K |
| Net profit | -$27.1M | -$30.5M | -$44.0M | -$35.1M |
| EBITDA | -$20.9M | -$26.7M | -$32.2M | -$28.0M |
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is mixed
More than 3 million Twist Bioscience (TWST) shares make up State Street's reported stake.
NeutralNov 10Twist Bioscience’s CEO and CFO will appear in live webcasts, with replays available for 30 days.
NeutralNov 9Form 144 Twist Bioscience Corp For: 7 November By Investing.com
NeutralNov 7A required tax sale leaves Twist Bioscience (TWST) COO Finn holding 180,278 shares directly.
Leans bearishNov 6Twist Bioscience Corporation (TWST) latest stock news and headlines
NeutralNov 5Tax withholding prompts a nondiscretionary 148-share sale at Twist Bioscience (TWST).
Leans bearishNov 5Twist Bioscience (TWST) CEO sells 4,573 shares to cover stock-vesting taxes, not discretionarily.
NeutralNov 5A Fidelity trust has a 5.2% interest in Twist Bioscience (TWST) as FMR updates its stake disclosure.
NeutralNov 522 macro signals shaping TWST right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
